LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Aspen API
03 1Jai Radhe Sales
04 1Vamsi Labs
05 1Aarti Pharmalabs
06 1TAPI Technology & API Services
07 1Beijing Breathgreen Healthcare
08 1Cipla
09 1FDC
10 1Guangzhou Tosun Pharmaceutical
11 1Hunan Warrant Chiral Pharmaceutical
12 1Jayco Chemical Industries
13 1Olon S.p.A
14 1Shouyuan Chemical
15 1Sifavitor srl
16 1Sun Pharmaceutical Industries Limited
17 1Zhejiang Apeloa Jiayuan Pharmaceutical
01 5China
02 7India
03 1Israel
04 2Italy
05 1Netherlands
06 1U.S.A
01 6Active
02 1Inactive
03 10Blank
01 17Blank
01 17Blank
01 1WC-0099
02 1WC-0168
03 15Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18236
Submission : 2005-04-01
Status : Active
Type : II
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-03-07
Pay. Date : 2013-02-14
DMF Number : 20557
Submission : 2007-05-23
Status : Active
Type : II
Date of Issue : 2023-01-06
Valid Till : 2025-07-29
Written Confirmation Number : WC-0099
Address of the Firm :
NDC Package Code : 15308-0310
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18433
Submission : 2005-06-16
Status : Active
Type : II
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19131
Submission : 2006-01-25
Status : Active
Type : II
NDC Package Code : 53104-7719
Start Marketing Date : 2018-12-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (4kg/4kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-18
Pay. Date : 2014-03-18
DMF Number : 28034
Submission : 2014-02-21
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-27
Pay. Date : 2014-02-14
DMF Number : 27663
Submission : 2014-02-14
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21394
Submission : 2008-03-05
Status : Inactive
Type : II
A Levalbuterol Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levalbuterol Hydrochloride, including repackagers and relabelers. The FDA regulates Levalbuterol Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levalbuterol Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levalbuterol Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levalbuterol Hydrochloride supplier is an individual or a company that provides Levalbuterol Hydrochloride active pharmaceutical ingredient (API) or Levalbuterol Hydrochloride finished formulations upon request. The Levalbuterol Hydrochloride suppliers may include Levalbuterol Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Levalbuterol Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 17 companies offering Levalbuterol Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?